These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 23362344)

  • 1. Human pluripotent stem cells: an emerging model in developmental biology.
    Zhu Z; Huangfu D
    Development; 2013 Feb; 140(4):705-17. PubMed ID: 23362344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity.
    Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128
    [No Abstract]   [Full Text] [Related]  

  • 3. Discovery of a Novel Polymer for Human Pluripotent Stem Cell Expansion and Multilineage Differentiation.
    Celiz AD; Smith JG; Patel AK; Hook AL; Rajamohan D; George VT; Flatt L; Patel MJ; Epa VC; Singh T; Langer R; Anderson DG; Allen ND; Hay DC; Winkler DA; Barrett DA; Davies MC; Young LE; Denning C; Alexander MR
    Adv Mater; 2015 Jul; 27(27):4006-12. PubMed ID: 26033422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cells.
    Moon SH; Ban K; Kim C; Kim SS; Byun J; Song MK; Park IH; Yu SP; Yoon YS
    Int J Cardiol; 2013 Sep; 168(1):41-52. PubMed ID: 23044428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Pluripotent Stem Cells for High-Throughput Drug Screening and Characterization of Small Molecules.
    Ryu S; Chu PH; Malley C; Braisted J; Ormanoglu P; Huang R; Itkin M; Itkin Z; Shinn P; Klumpp-Thomas C; Michael S; Tristan CA; Simeonov A; Singeç I
    Methods Mol Biol; 2022; 2454():811-827. PubMed ID: 34128205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanobiology: a new frontier for human pluripotent stem cells.
    Sun Y; Fu J
    Integr Biol (Camb); 2013 Mar; 5(3):450-7. PubMed ID: 23337973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering Strategies for the Formation of Embryoid Bodies from Human Pluripotent Stem Cells.
    Pettinato G; Wen X; Zhang N
    Stem Cells Dev; 2015 Jul; 24(14):1595-609. PubMed ID: 25900308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adapting human pluripotent stem cells to high-throughput and high-content screening.
    Desbordes SC; Studer L
    Nat Protoc; 2013 Jan; 8(1):111-30. PubMed ID: 23257981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learn from Your Elders: Developmental Biology Lessons to Guide Maturation of Stem Cell-Derived Cardiomyocytes.
    Marchianò S; Bertero A; Murry CE
    Pediatr Cardiol; 2019 Oct; 40(7):1367-1387. PubMed ID: 31388700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The advancement of human pluripotent stem cell-derived therapies into the clinic.
    Thies RS; Murry CE
    Development; 2015 Sep; 142(18):3077-84. PubMed ID: 26395136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.
    Irion S; Nostro MC; Kattman SJ; Keller GM
    Cold Spring Harb Symp Quant Biol; 2008; 73():101-10. PubMed ID: 19329573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Current State of Naïve Human Pluripotency.
    Dodsworth BT; Flynn R; Cowley SA
    Stem Cells; 2015 Nov; 33(11):3181-6. PubMed ID: 26119873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Dose Irradiation Enhances Gene Targeting in Human Pluripotent Stem Cells.
    Hatada S; Subramanian A; Mandefro B; Ren S; Kim HW; Tang J; Funari V; Baloh RH; Sareen D; Arumugaswami V; Svendsen CN
    Stem Cells Transl Med; 2015 Sep; 4(9):998-1010. PubMed ID: 26185257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene targeting in human pluripotent stem cells.
    Liu Y; Rao M
    Methods Mol Biol; 2011; 767():355-67. PubMed ID: 21822888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments.
    McGivern JV; Ebert AD
    Adv Drug Deliv Rev; 2014 Apr; 69-70():170-8. PubMed ID: 24309014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells.
    Yanagihara K; Liu Y; Kanie K; Takayama K; Kokunugi M; Hirata M; Fukuda T; Suga M; Nikawa H; Mizuguchi H; Kato R; Furue MK
    Stem Cells Dev; 2016 Dec; 25(24):1884-1897. PubMed ID: 27733097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways governing development of stem cell-derived pancreatic β cells: lessons from embryogenesis.
    Al-Khawaga S; Memon B; Butler AE; Taheri S; Abou-Samra AB; Abdelalim EM
    Biol Rev Camb Philos Soc; 2018 Feb; 93(1):364-389. PubMed ID: 28643455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates.
    Abraham S; Sheridan SD; Miller B; Rao RR
    Biotechnol Prog; 2010; 26(4):1126-34. PubMed ID: 20730767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic approaches to dissect biological processes in stem cells by image-based screening.
    Erdmann G; Volz C; Boutros M
    Biotechnol J; 2012 Jun; 7(6):768-78. PubMed ID: 22653826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OLIG gene targeting in human pluripotent stem cells for motor neuron and oligodendrocyte differentiation.
    Liu Y; Jiang P; Deng W
    Nat Protoc; 2011 May; 6(5):640-55. PubMed ID: 21527921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.